drugset / Trial / NCT00735774

Suitability of 11C-ORM-13070 as a PET Tracer

NCT00735774 ↗

Phase 1 Completed 18 enrolled Orion Corporation, Orion Pharma
Non-randomizedSingle-groupOpen-label

Summary

The purpose of the study is to evaluate the suitability of 11C-ORM-13070 as a positron emission tomography tracer.

Timeline

Start
2008-08
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject 11C-ORM-13070 Diagnostic / imaging agent — Intravenous

Indications

No indication recorded.